What does Dr. Frank Chielens Algemene Geneeskunde do?

Dr. Frank Chielens Algemene Geneeskunde is a research organisation in Ieper. Private Limited, started on 27 June 1991, 1 establishment.

What is the address of Dr. Frank Chielens Algemene Geneeskunde?

The registered office of Dr. Frank Chielens Algemene Geneeskunde is located at Duivenstraat 4, 8900 Ieper.

Is Dr. Frank Chielens Algemene Geneeskunde still active?

Yes. According to the CBE (16 September 2026) Dr. Frank Chielens Algemene Geneeskunde is active, legal situation “Normale toestand”, started on 27 June 1991.

Is Dr. Frank Chielens Algemene Geneeskunde registered on Peppol?

Yes, Dr. Frank Chielens Algemene Geneeskunde is registered on the Peppol network with ID 0208:0444485078.

What is the enterprise number of Dr. Frank Chielens Algemene Geneeskunde?

The enterprise number of Dr. Frank Chielens Algemene Geneeskunde is BE0444485078.

When was Dr. Frank Chielens Algemene Geneeskunde founded?

Dr. Frank Chielens Algemene Geneeskunde was founded on 27 June 1991.

Who are the directors of Dr. Frank Chielens Algemene Geneeskunde?

According to the 2025 annual accounts, the directors of Dr. Frank Chielens Algemene Geneeskunde are: Frank Chielens.

Is Dr. Frank Chielens Algemene Geneeskunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Frank Chielens Algemene Geneeskunde make in 2025?

Dr. Frank Chielens Algemene Geneeskunde posted a profit after taxes of € 14,396 in financial year 2025.

What is the revenue of Dr. Frank Chielens Algemene Geneeskunde?

As a small company, Dr. Frank Chielens Algemene Geneeskunde is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 23,306.

Dr. Frank Chielens Algemene Geneeskunde (Private Limited)

Dossier Dr. Frank Chielens Algemene Geneeskunde, printed on 16 September 2026 from databakkes.be/en/0444485078/dr-frank-chielens-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Frank Chielens Algemene Geneeskunde from Ieper, company number BE0444485078, closed financial year 2025 with a result of € 14,396 after tax. For that financial year Dr. Frank Chielens Algemene Geneeskunde recorded a gross margin of € 23,306 and equity of € 64,115. Compared with financial year 2024, the result moved from € 10,819 to € 14,396. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.

What it is worth Growing

€ 64,115

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,396

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,749

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 13,659 paid out

95 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,618

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 137

▼ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,997

▲ 51% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 23,593 Gross margin 2022: € 23,593 First fiscal year in the series	€ 7,671 Gross margin 2023: € 7,671 ▼ 67% vs 2022 (€ 23,593) Unfavourable step	€ 21,135 Gross margin 2024: € 21,135 ▲ 176% vs 2023 (€ 7,671) Favourable step	€ 23,306 Gross margin 2025: € 23,306 ▲ 10% vs 2024 (€ 21,135) Favourable step	▲ 10%
Profit after taxes	€ 16,680 Profit after taxes 2022: € 16,680 First fiscal year in the series	€ 3,909 Profit after taxes 2023: € 3,909 ▼ 77% vs 2022 (€ 16,680) Unfavourable step	€ 10,819 Profit after taxes 2024: € 10,819 ▲ 177% vs 2023 (€ 3,909) Favourable step	€ 14,396 Profit after taxes 2025: € 14,396 ▲ 33% vs 2024 (€ 10,819) Favourable step	▲ 33%
Equity	€ 60,649 Equity 2022: € 60,649 First fiscal year in the series	€ 64,558 Equity 2023: € 64,558 ▲ 6% vs 2022 (€ 60,649) Favourable step	€ 63,378 Equity 2024: € 63,378 ▼ 2% vs 2023 (€ 64,558) Unfavourable step	€ 64,115 Equity 2025: € 64,115 ▲ 1% vs 2024 (€ 63,378) Favourable step	▲ 1%
Total debts	€ 15,424 Total debts 2022: € 15,424 First fiscal year in the series	€ 9,033 Total debts 2023: € 9,033 ▼ 41% vs 2022 (€ 15,424) Favourable step	€ 7,908 Total debts 2024: € 7,908 ▼ 12% vs 2023 (€ 9,033) Favourable step	€ 4,393 Total debts 2025: € 4,393 ▼ 44% vs 2024 (€ 7,908) Favourable step	▼ 44%
Cash	€ 63,965 Cash 2022: € 63,965 First fiscal year in the series	€ 56,419 Cash 2023: € 56,419 ▼ 12% vs 2022 (€ 63,965) Unfavourable step	€ 33,756 Cash 2024: € 33,756 ▼ 40% vs 2023 (€ 56,419) Unfavourable step	€ 31,749 Cash 2025: € 31,749 ▼ 6% vs 2024 (€ 33,756) Unfavourable step	▼ 6%
Retained profit	€ 48,249 Retained profit 2022: € 48,249 First fiscal year in the series	€ 52,158 Retained profit 2023: € 52,158 ▲ 8% vs 2022 (€ 48,249) Favourable step	€ 62,978 Retained profit 2024: € 62,978 ▲ 21% vs 2023 (€ 52,158) Favourable step	€ 63,715 Retained profit 2025: € 63,715 ▲ 1% vs 2024 (€ 62,978) Favourable step	▲ 1%
Dividend	€ 16,000 Dividend 2022: € 16,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 16,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 13,659 Dividend 2025: € 13,659 Unchanged (€ 0) Unchanged
Balance sheet total	€ 76,073 Balance sheet total 2022: € 76,073 First fiscal year in the series	€ 73,591 Balance sheet total 2023: € 73,591 ▼ 3% vs 2022 (€ 76,073) Unchanged	€ 71,286 Balance sheet total 2024: € 71,286 ▼ 3% vs 2023 (€ 73,591) Unchanged	€ 68,508 Balance sheet total 2025: € 68,508 ▼ 4% vs 2024 (€ 71,286) Unchanged	▼ 4%

Key figures of Dr. Frank Chielens Algemene Geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Frank Chielens Algemene Geneeskunde?

What happened at Dr. Frank Chielens Algemene Geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 10, 2026 New annual accounts for financial year 2025: profit of € 14,396 (▲ 33% vs 2024). Source: NBB ↗
2009 Frank Chielens became a director. NBB
Jun 27, 1991 New establishment in Ieper. KBO
Jun 27, 1991 Start of the company according to the CBE. KBO

In short

From € 16,680 profit in 2022 to € 14,396 profit in 2025.

Paid € 21,754 in corporate taxes since 2022.

Best year ever: 2022, with € 16,680 profit.

Paid out € 29,659 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Frank Chielens Algemene Geneeskunde? We notify you, reason included.

Follow Dr. Frank Chielens Algemene Geneeskunde

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Frank Chielens

Dr. Frank Chielens Algemene Geneeskunde

Behind Dr. Frank Chielens Algemene Geneeskunde is Frank Chielens.

See the full network in the app

Directors

According to the 2025 annual accounts

Frank Chielens

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Duivenstraat 4

8900 Ieper

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0444.485.078

VAT number

BE 0444.485.078

Registered office

Duivenstraat 4, 8900 Ieper

Names & denominations

Dr. Frank Chielens Algemene Geneeskunde

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 June 1991

Peppol

Active · Active since 15 May 2025

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Frank Chielens Algemene Geneeskunde

Financials

What happened to Dr. Frank Chielens Algemene Geneeskunde?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions